CREAL Secures $8.9 Million Investment to Enhance Vision Care and AR Technologies

CREAL Secures $8.9 Million Investment to Transform Vision Care and Augmented Reality Technology



In a significant move for the tech and healthcare sectors, Swiss startup CREAL has closed an $8.9 million equity funding round, primarily led by the esteemed optical and optoelectronic company, ZEISS. Participating in this investment round were various new and existing stakeholders, including members associated with the UBS private investor network. This funding marks a pivotal point in CREAL's journey, emphasizing the increasing interest in light field technology and its promising capabilities in enhancing vision care and augmented reality (AR) applications.

The capital raised will be allocated to advance and deploy CREAL's innovative light field display technology. One of the primary focuses will be on developing a digitized vision care platform that aligns with ZEISS’s upcoming diagnostic and treatment devices. This partnership is set to revolutionize the experience of vision care, making it more efficient and accessible through ground-breaking technology.

CEO and Co-Founder Tomas Sluka expressed his vision regarding the intersection of AR and everyday life, stating, "As AI reshapes how we work and create, AR is positioned as a pivotal interface for this new age. If people are to wear AR glasses throughout the day, comfort, health, and natural usability must be prioritized. Our goal is to provide AR glasses that project digital images with real-world depth, thus supporting the human eye's natural focus mechanism—key to achieving immersive spatial computing." This deliberate approach aims to ensure that AR glasses are not only technology-oriented but also user-friendly and beneficial to eye health.

The newly secured investment round puts CREAL's total funding to date at over $32 million, solidifying its stature among leaders in AR display innovation. Key players in this funding journey have included Swisscom Ventures, Verve Ventures, DAA Capital Partners, and of course, ZEISS. This broadening circle of investment demonstrates substantial confidence in CREAL’s trajectory in the increasingly competitive landscapes of vision care and digital displays.

At its core, CREAL is a display technology innovator, situated in Switzerland. The company’s technical team comprises highly skilled professionals drawn from illustrious tech projects at Intel, Magic Leap, EPFL, and CERN. The team has developed a proprietary light field micro-display technology, which expertly projects images that convey genuine depth perception. This capability ensures that while extending its reach into AR, CREAL remains focused on enhancing vision care—creating a necessary balance in visual experiences, particularly as the demand for gadget integration grows in both consumer and enterprise markets.

In summary, the recent financing round represents not only a financial triumph for CREAL but also a visionary leap towards transforming how we perceive and interact with our visual environments—both in health care and everyday digital engagements. The partnership with ZEISS paves the way for future innovations that promise to shape the future of supportive vision care and outstanding augmented reality experiences. To learn more about CREAL and its groundbreaking technologies, visit creal.com.

Topics Consumer Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.